Selective Activation of CD8 T Cell Effector Functions by Epitope Variants of Lymphocytic Choriomeningitis Virus Glycoprotein

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2358-2365

  Martin, Stefan ^a,c   Kohler, Hubertus ^a   Weltzien, Hans Ulrich ^a   Leipner, Carola ^b  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; EPITOPE; GLYCOPROTEIN; GLYCOPROTEIN PEPTIDE 33 41, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; GLYCOPROTEIN PEPTIDE 33-41, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; LIGAND; PEPTIDE FRAGMENT; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL; ARTICLE; BINDING COMPETITION; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL LINE; CYTOTOXICITY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; METABOLISM; MOUSE; PROTEIN BINDING;

ANIMALS; ANTIGENS, VIRAL; BINDING, COMPETITIVE; CALCIUM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GLYCOPROTEINS; H-2 ANTIGENS; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PROTEIN BINDING; VIRAL PROTEINS;

EID: 0030587163     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
2. O'Rourke, A. M., and M. F. Mescher. 1992. Cytoloxic T-lymphocyte activation involves a cascade of signalling and adhesion events. Nature 358:253.
3. O'Rourke, A. M., and M. F. Mescher. 1994. Signals for activation of CD8-dependent adhesion and costimulation. J. Immunol 152:4358.
4. Mondino, A., and M. K. Jenkins. 1994. Surface proteins involved in T cell co-stimulation. J. Leukocyte Biol. 55:805.
5. Perlmutter, R. M., S. D. Levin, M. W. Appleby, S. J. Anderson, and J. Alberola-Ila. 1993. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11:451.
6. Chan, A. C., D. M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol 12:555.
7. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
8. Evavold, B. D., J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
9. + T cells by a self-derived peptide. Nature 378:295.
10. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-presenting cells. Nature 363:156.
11. Hollsberg, P., W. E. J. Weber, F. Dangond, V. Batra, A. Sette, and D. A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotrophic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 92:4036.
12. Jameson, S. C., F. R. Carbone, and M. J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541.
13. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Philipps, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
14. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
15. DeMagistris, T. M., J. Alexander, F. C. A. Gaeta, H. M. Grey, and A. Sette. 1992. Analog antigen/MHC complexes act as antagonists of the T cell receptor. Cell 68:625.
16. Pircher, H., D. Moskophidis, U. Rohrer, K. Bùrki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629.
17. Bertoletti, A., A. Costanro, F. V. Chisari, M. Levrero, M. Artini, A. Seite, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933.
18. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus I NEF protein. J. Exp. Med. 180:1129.
19. Pircher, H., J. Baenziger, M. Schilham, T. Sado, H. Kamisaku, H. Hengartner, and R. M. Zinkernagel. 1987. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras. Eur. J. Immunol. 17:159.
20. Martin, S., H. Ruh, S. Hebbelmann, U. Pflugfelder, B. Rüde, and H. U. Weltzien. 1995. Carrier-reactive hapten-specific CTL clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity. Eur. J. Immunol. 25:2788.
21. Anderson, K. S., J. Alexander, M. Wei, and P. Cresswell. 1993. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J. Immunol. 151:3407.
22. Ljunggren, H.-G., and K. Kärre. 1985. Host resistance directed selectively against H-2 deficient lymphoma variants. J. Exp. Med. 162:1745.
23. Weltzien, H. U., S. Hebbelmann, U. Pflugfelder, H. Ruh, B. Ortmann, S. Martin, and A. Iglesias. 1992. Antigen contact sites in class I MHC-restricted, trinitrophenyl-specific T cell receptors. Eur. J. Immunol. 22:863.
24. Martin, S., A. v. Bonin, C. Fessler, U. Pflugfelder, and H. U. Weltzien. 1993. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specitic T cells. J. Immunol. 151:678.
25. 51Cr-labelled allogeneic target cells in vitro. Inhibition by isoantibody and by drugs. Immunology 14:181.
26. Spitalny, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral macrophage tumoricidal activities. J. Exp. Med. 159:1560.
27. Prat, M., G. Gribaudo, P. M. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine gamma interferon. Proc. Natl. Acad. Sci. USA 81:4515.
28. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
29. Falk, K., O. Rötzschke, S. Stefanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
30. b. Science 257:919.
31. Matsumura, M., D. H. Fremont, P. A. Peterson, and I. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
32. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 76:39.
33. Kast, W. M., and C. J. M. Melief. 1991. Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus-induced tumours and peptide-MHC binding. Int. J. Cancer 6(Suppl.):90.
34. Lewicki, H., A. Tishon, P. Borrow, C. F. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell, I. A. Wilson, and M. B. A. Oldstone. 1995. CTL escape variants. I. Generation and molecular characterization. Virology 210:29.
35. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell 79:913.
36. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. ζ-Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
37. Valitutti, S., S. Millier, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
38. McKeithan, T. W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92:5042.
39. Rabinowitz, J. D., C. Beeson, D. S. Lyons, M. M. Davis, and H. M. McConnell. 1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA 93:1401-1405.
40. Valitutti, S., S. Müller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
41. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
42. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
43. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.